FR2374309B1 - - Google Patents
Info
- Publication number
- FR2374309B1 FR2374309B1 FR7738009A FR7738009A FR2374309B1 FR 2374309 B1 FR2374309 B1 FR 2374309B1 FR 7738009 A FR7738009 A FR 7738009A FR 7738009 A FR7738009 A FR 7738009A FR 2374309 B1 FR2374309 B1 FR 2374309B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C273/00—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C273/18—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas
- C07C273/1809—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety
- C07C273/1818—Preparation of urea or its derivatives, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups of substituted ureas with formation of the N-C(O)-N moiety from -N=C=O and XNR'R"
- C07C273/1827—X being H
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB52955/76A GB1598662A (en) | 1976-12-18 | 1976-12-18 | 10,12-diazoprostaglandins |
GB3036977 | 1977-07-20 |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2374309A1 FR2374309A1 (fr) | 1978-07-13 |
FR2374309B1 true FR2374309B1 (fr) | 1980-05-16 |
Family
ID=26260409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7738009A Granted FR2374309A1 (fr) | 1976-12-18 | 1977-12-16 | Compose a cycle diazole utilisable comme medicament |
Country Status (15)
Country | Link |
---|---|
JP (1) | JPS5382779A (fr) |
AT (1) | AT368498B (fr) |
AU (1) | AU514523B2 (fr) |
CH (1) | CH639076A5 (fr) |
DE (1) | DE2755771A1 (fr) |
DK (1) | DK551777A (fr) |
ES (1) | ES465176A1 (fr) |
FI (1) | FI773812A (fr) |
FR (1) | FR2374309A1 (fr) |
IL (1) | IL53559A0 (fr) |
NL (1) | NL7713971A (fr) |
NO (1) | NO774348L (fr) |
NZ (1) | NZ185909A (fr) |
PH (1) | PH14398A (fr) |
SE (1) | SE7714373L (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4337262A (en) | 1977-12-01 | 1982-06-29 | Burroughs Wellcome Co. | Hydantoin derivatives, pharmaceutical compounds and methods of use |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK543178A (da) * | 1977-12-01 | 1979-06-02 | Wellcome Found | Thiodydantoinderivater |
DE2963795D1 (en) * | 1978-01-23 | 1982-11-11 | Beecham Group Plc | Hydantoins and thiohydantoins, method for their preparation and pharmaceutical compositions containing them |
EP0004723A1 (fr) * | 1978-03-30 | 1979-10-17 | Beecham Group Plc | Déoxyhydantoines, leurs procédés de préparation et compositions pharmaceutiques les contenant |
EP0006352A1 (fr) * | 1978-06-15 | 1980-01-09 | Beecham Group Plc | Hydantoines et thiohydantoines, procédé pour leur préparation et compositions pharmaceutiques les contenant |
AU4778279A (en) * | 1978-06-15 | 1979-12-20 | Beecham Group Limited | Prostaglandin analogues |
US4294972A (en) * | 1978-06-15 | 1981-10-13 | Beecham Group Limited | 1,2-Disubstituted oxo triazolidine |
IL57504A0 (en) * | 1978-06-15 | 1979-10-31 | Beecham Group Ltd | Prostagandin analogues,their preparation and pharmaceutical compositions containing |
GB2050371A (en) * | 1979-05-09 | 1981-01-07 | Wellcome Found | Optically active hydantoin derivatives and pharmaceutical formulations containing them |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2323193A1 (de) | 1972-05-10 | 1973-11-22 | Du Pont | Pyrazolidinone |
FR2258376A1 (en) | 1974-01-21 | 1975-08-18 | Aries Robert | 10-Aza prostaglandins - for treatment of blood pressure and gastro-intestinal disorders and in prepn for confinement |
GB1524818A (en) | 1974-11-29 | 1978-09-13 | Beecham Group Ltd | 12-azaprostaglandins |
-
1977
- 1977-12-07 IL IL53559A patent/IL53559A0/xx unknown
- 1977-12-08 NZ NZ185909A patent/NZ185909A/xx unknown
- 1977-12-09 DK DK551777A patent/DK551777A/da not_active Application Discontinuation
- 1977-12-14 DE DE19772755771 patent/DE2755771A1/de not_active Withdrawn
- 1977-12-14 AT AT0893777A patent/AT368498B/de not_active IP Right Cessation
- 1977-12-15 AU AU31613/77A patent/AU514523B2/en not_active Expired
- 1977-12-16 FI FI773812A patent/FI773812A/fi not_active Application Discontinuation
- 1977-12-16 NO NO774348A patent/NO774348L/no unknown
- 1977-12-16 FR FR7738009A patent/FR2374309A1/fr active Granted
- 1977-12-16 NL NL7713971A patent/NL7713971A/xx not_active Application Discontinuation
- 1977-12-16 CH CH1554577A patent/CH639076A5/de not_active IP Right Cessation
- 1977-12-16 ES ES465176A patent/ES465176A1/es not_active Expired
- 1977-12-16 SE SE7714373A patent/SE7714373L/xx not_active Application Discontinuation
- 1977-12-19 JP JP15279377A patent/JPS5382779A/ja active Pending
- 1977-12-19 PH PH20569A patent/PH14398A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4337262A (en) | 1977-12-01 | 1982-06-29 | Burroughs Wellcome Co. | Hydantoin derivatives, pharmaceutical compounds and methods of use |
Also Published As
Publication number | Publication date |
---|---|
AU3161377A (en) | 1979-06-21 |
SE7714373L (sv) | 1978-06-19 |
NL7713971A (nl) | 1978-06-20 |
CH639076A5 (en) | 1983-10-31 |
NO774348L (no) | 1978-06-20 |
AT368498B (de) | 1982-10-11 |
ATA893777A (de) | 1982-02-15 |
IL53559A0 (en) | 1978-03-10 |
DK551777A (da) | 1978-06-19 |
JPS5382779A (en) | 1978-07-21 |
NZ185909A (en) | 1980-11-14 |
FR2374309A1 (fr) | 1978-07-13 |
ES465176A1 (es) | 1979-01-01 |
DE2755771A1 (de) | 1978-06-29 |
AU514523B2 (en) | 1981-02-12 |
PH14398A (en) | 1981-06-25 |
FI773812A (fi) | 1978-06-19 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |